Grifols · 20 hours ago
Intern - Value, Access & Pricing (VAP) Analytics
Grifols is a global healthcare company that has been improving health and well-being since 1909. They are seeking a Value, Access & Pricing (VAP) Analytics Intern to support key initiatives in Pricing, Market Access, and Account Management, providing a hands-on learning opportunity in a global biopharmaceutical context.
BiotechnologyHealthcareManufacturingHealth Care
Responsibilities
Assist with collecting, validating, and analyzing datasets related to the Grifols product portfolio
Support pricing and contracting activities, including bid proposal analysis
Help evaluate prior contracts through simple ROI reviews, customer‑level pricing assessments, and profitability checks
Support competitive benchmarking by researching competitor pricing, payer trends, and industry updates
Assist in developing dashboards, reports, and business review materials to monitor performance and track key market trends
Work with team members across VAP, Brand and other departments to support ongoing projects
Qualification
Required
Strong analytical, quantitative, and problem‑solving skills
High proficiency in Microsoft Excel and PowerPoint
Ability to interpret data and summarize findings clearly and concisely
Strong attention to detail and the ability to handle multiple tasks in a fast‑paced environment
Applicants for the internship should be currently pursuing a Bachelor's or Master's degree in Business Administration, Finance, Accounting or a related field with a GPA of 3.0 or better
Preferred
Basic understanding of the U.S. payer, reimbursement, or market access environment
Knowledge or exposure to pharmaceutical pricing, market access concepts, or healthcare‑related coursework
Company
Grifols
Grifols is a global healthcare company.
Funding
Current Stage
Public CompanyTotal Funding
$2.51BKey Investors
Michael J. Fox Foundation
2025-01-14Grant· $21M
2024-06-04Post Ipo Debt· $1.41B
2024-04-23Post Ipo Debt· $1.07B
Leadership Team
Recent News
capital-riesgo.es
2026-02-07
2025-12-24
Company data provided by crunchbase